CIK 0001326190 · Non-accelerated filer<br>Smaller reporting company
Altimmune, Inc.
Sign in to watch- Ticker
- ALT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 202726770
- Phone
- 862-457-1450
- Business address
- 350 MOUNT KEMBLE AVENUE, SUITE 1001, MORRISTOWN, NJ, 07960
- Former names
- PHARMATHENE, INC, HEALTHCARE ACQUISITION CORP
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-09-24 | Pisano Wayne Director | Option exercise · Restricted Stock Units ("RSUs") | −16,850 | 0 | ||
| 2020-09-24 | Schafer Klaus Director | Option exercise | +16,850 | 17,050 | ||
| 2020-09-24 | Schafer Klaus Director | Option exercise · Restricted Stock Units ("RSUs") | −16,850 | 0 | ||
| 2020-09-24 | Hodges Philip Director | Option exercise | +16,850 | 36,306 | ||
| 2020-09-24 | Hodges Philip Director | Option exercise · Restricted Stock Units ("RSUs") | −16,850 | 0 | ||
| 2020-09-24 | Hodges Philip Director | Grant or award · Stock Options (option to buy) | +25,500 | 25,500 | ||
| 2020-09-24 | SAYARE MITCHEL Director | Grant or award · Stock Options (option to buy) | +25,500 | 25,500 | ||
| 2020-09-24 | Pisano Wayne Director | Grant or award · Stock Options (option to buy) | +25,500 | 25,500 | ||
| 2020-09-24 | Jorkasky Diane Director | Grant or award · Stock Options (option to buy) | +9,500 | 9,500 | ||
| 2020-09-24 | Drutz David Director | Grant or award · Stock Options (option to buy) | +25,500 | 25,500 | ||
| 2020-09-24 | Schafer Klaus Director | Grant or award · Stock Options (option to buy) | +25,500 | 25,500 | ||
| 2020-09-24 | GILL JOHN Director | Grant or award · Stock Options (option to buy) | +25,500 | 25,500 | ||
| 2020-08-30 | Garg Vipin K President & CEO | Shares withheld for taxes | −2,015 | $17.62 | $36K | 323,774 |
| 2020-07-31 | Harris Matthew Scott Chief Medical Officer | Grant or award | +8,084 | $1.46 | $12K | 8,084 |
| 2020-07-31 | Brown William Michael Chief Financial Officer | Grant or award | +7,920 | $1.46 | $12K | 15,981 |
| 2020-07-31 | Roberts M Scot Chief Scientific Officer | Grant or award | +3,859 | $1.46 | $6K | 9,394 |
| 2020-07-31 | Garg Vipin K Chief Financial Officer | Grant or award | +11,674 | $1.46 | $17K | 325,789 |
| 2020-07-30 | Garg Vipin K President and CEO | Shares withheld for taxes | −2,015 | $26.06 | $53K | 314,115 |
| 2020-06-30 | Garg Vipin K President and CEO | Shares withheld for taxes | −2,015 | $10.71 | $22K | 316,130 |
| 2020-06-25 | Drutz David Director | Grant or award · Restricted Stock Units ("RSUs") | +16,850 | 16,850 |
Page 22 of 29 · 568 trades